CCR6 and rheumatoid arthritis: We have previously shown that combining the active vitamin D metabolite 1,25(OH)2D3 with TNFα blockade, a commonly used therapy in RA, additively suppresses the proinflammatory loop between CCR6+ memTh and RASF [10].